Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer

Archives of Iranian Medicine

Volumn 16, Issue 6, 2013, Pages 320-323

  Ghasemi Kebria, Fatemeh ^a   Roshandel, Gholamreza ^a,b   Semnani, Shahryar ^a   Shakeri, Ramin ^b   Khoshnia, Masoud ^a   Naeimi Tabiei, Mohammad ^a   Merat, Shahin ^b   Malekzadeh, Reza ^b  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenocarcinoma; Epidemiology; Esophagus; Golestan; Iran

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; STOMACH ADENOCARCINOMA; TREND STUDY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; REGISTRIES; RISK FACTORS;

EID: 84878858843     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008, cancer incidence and mortality worldwide: Iarc cancerbase no. 10. Lyon: International Agency for Research on Cancer. 2010; Available from: URL: http://globocan.iarc.fr (Accessed Date: 03/02/2011).
2. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian Littoral of Iran: The Caspian Cancer Registry. BrJ Cancer. 1973; 28: 197-214.
3. Das A. Tumors of the esophagus. In: Feldman M, Friedman L, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, and Management. 9th ed. Philadelphia: Saunders Elsevier; 2010: 745-770.
4. Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer. 2009; 101: 1-6.
5. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence infive continents, vol. Viii. Lyon: IARC; 2002.
6. Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffeta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran-a review. Eur J Cancer. 2009; 45: 3156-3165.
7. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F. Esophageal cancer in northeastern Iran: a review. Arch Iran Med. 2007; 10: 70-82.
8. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001; 92: 549-555.
9. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008; 100: 1184-1187.
10. Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. JSurg Oncol. 2005; 92: 151-159.
11. Blot WJ, Devesa SS, Kneller RW, Fraumeni Jr JF. Rising incidence of adenocarcinoma of the esophagus and ngastric cardia. JAMA. 1991; 265: 1287-1289.
12. Vega KJ, Jamal MM. Changing pattern of esophageal cancer incidence in New Mexico. Am J Gastroenterol. 2000; 95: 2352-2356.
13. El-Serag H, Mason A, Petersen N, Key C. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002; 50: 368-372.
14. Zhang ZF, Kurtz RC, Sun M, Karpeh M Jr, Yu GP, Gargon N, et al. Adenocarcinomas of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev. 1996; 5: 761-768.
15. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995; 4: 85-92.
16. Chow WH, Fraumeni Jr JF, Blot WJ, Vaughan TL, Stanford JL, Farrow DC, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998; 90: 150-155.
17. Ajlouni K, Jaddou H, Batieha A. Obesity in Jordan. Int J Obes. 1998; 22: 624-628.
18. Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA, Arafah MR, Khalil MZ, Khan NB, et al. Obesity in Saudi Arabia. Saudi Med J. 2005; 26: 824-829.
19. Malekzadeh R Mohamadnejad M, Merat S, Pourshams A, Etemadi A. Obesity pandemic: An Iranian perspective. Arch Iran Med. 2005; 8: 1-7.
20. Warsy A, El-Hazmi M. Diabetes mellitus, hypertension, and obesity-common multifactorial disorders in Saudis. East Mediterr Health J. 1999; 5: 1236-1242.
21. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis. 2007; 8: 179-185.
22. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat S, Nouraie S, et al. Cancer incidence in Golestan Province: Report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012; 15: 196.
23. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, et al. Epidemiologic features of upper gastrointestinal tract cancers in northeastern Iran. Br J Cancer. 2004; 90: 1402-1406.
24. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006; 6: 158.
25. Statistical Research and Applications Branch. Joinpoint regression program. 3.5.4 eds. Bethesda: National Cancer Institute; 2012.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. StatMed. 2000; 19: 335-351.
27. Blot WJ, Mclaughlin JK, editors. The changing epidemiology of esophageal cancer. Seminars in Oncology; 1999.
28. Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res. 2000; 155: 1-14.
29. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340: 825-831.
30. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999; 130: 883-890.
31. Pohl H, Wrobel K, Bojarski C, Voderholzer W, Sonnenberg A, Rosch T, et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol. 2013; 108: 200-207.
32. Graham DY The changing epidemiology of GERD: Geography and Helicobacter pylori. Am J Gastroenterol. 2003; 98: 1462-1470.
33. Ehsani MJ, Maleki I, Mohammadzadeh F, Mashayekh A. Epidemiology of gastroesophageal reflux disease in Tehran, Iran. J Gastroenterol Hepatol. 2007; 22: 1419-1422.
34. Ghasemi-Kebria F, Bagheri H, Semnani S, Ghaemi E. Seroprevalence of anti-hp and anti-caga antibodies among healthy persons in Golestan Province, northeast of Iran (2010). Caspian J Intern Med. 2011; 2: 256-260.
35. Sukocheva O, Wee C, Ansar A, Hussey D, Watson D. Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells. Dis Esophagus. 2012; DOI: 10.1111/dote.12000.
36. Etzioni R, Penson DF, Legler JM, Di Tommaso D, Boer R, Gann PH. Overdiagnosis due to prostate-specific antigen screening: Lessons from the U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94: 981-990.
37. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005; 97: 142-146.
38. Wei JT, Shaheen N. The changing epidemiology of esophageal adenocarcinoma. Semin GastrointestDis. 2003; 14: 112-127.